Results 141 to 150 of about 31,245 (262)

Scholarly productivity of non-pharmacy practice faculty in U.S. schools and colleges of pharmacy, 2019-2023. [PDF]

Explor Res Clin Soc Pharm
Shoair OA, Pollard S, Fosuhene-Apenteng F, Pimentel-Galvan M, Elagami A, Abdel Aziz MH.   +5 more
europepmc   +1 more source

(Intending) Migrants and Occupational Downgrading: Investigating the Willingness to Leave the Health Sector Post‐Migration

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT The unquenched thirst for emigration in Nigeria‐ and the increasing cost of migrating to the West‐has been established in the literature. Professionals, such as healthcare workers (HCWs), are poorly paid in Nigeria, making many seek better employment abroad.
Tunde A. Alabi, Oluwaseun Badru, Fatai A. Badru, Oluwafemi Adeagbo   +3 more
wiley   +1 more source

Cost-effectiveness of inclisiran in patients with atherosclerotic cardiovascular disease from Chinese healthcare perspective. [PDF]

PLoS One
Liu M, Zhang X, Feng M, He Q, Feng Z.
europepmc   +1 more source

Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long‐Term Follow‐Up From the CAP Randomised Trial

International Journal of Cancer, EarlyView.
Uncertainty persists over whether the benefits of prostate‐specific antigen (PSA) screening outweigh harms from overdiagnosis, a key barrier to population‐wide adoption. Here, English male mortality rates were analyzed alongside long‐term data from the UK Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) to estimate age‐specific ...
Adam R. Brentnall, Matejka Rebolj, Peter Sasieni, Garth Funston, Rhian Gabe, Andrew J. Vickers   +5 more
wiley   +1 more source

Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity. [PDF]

PLOS Glob Public Health
Rusatira JC, Pal E, Uwimana JB, Khan A, Novoa MD, Suryanarayanan S, Schoukroun-Barnes L, Peterson C, Michtalik H, Kapeta AB, Mukanga D, Ahmed S, Lumpkin M, Preston C.   +13 more
europepmc   +1 more source

Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort

International Journal of Cancer, EarlyView.
The immune system has been implicated as a major driver in pancreatic cancer etiology. Previous cohort studies have found associations between pancreatic cancer and single immune system‐derived markers, but omics‐based evidence remains scarce. In this prospective case–control study, the authors investigated 92 proteins involved in immune reactions and ...
Verena A. Katzke, Yue Chen, Srimanti Dutta, Federico Canzian, Julie Louise Munk Andersen, Agnetha Linn Rostgaard‐Hansen, Léa Bouteille, Vinciane Rebours, Thérèse Truong, Matthias B. Schulze, Benedetta Bendinelli, Valeria Pala, Vittorio Simeon, Rosario Tumino, Carlotta Sacerdote, Roel Vermeulen, P. Martijn Kolijn, Sjoerd G. Elias, Marta Crous‐Bou, Maria‐José Sánchez, Ana Jimenez‐Zabala, José María Huerta, Marcela Guevara, Nick Wareham, Marie Breeur, Mattias Johansson, James Yarmolinsky, Daniele Campa, Rudolf Kaaks   +28 more
wiley   +1 more source

The inaugural HEMA report: a missed opportunity for comprehensive value assessment. [PDF]

J Comp Eff Res
Westrich K, Wagner TD, Campbell JD.
europepmc   +1 more source

Can the Parallel or Tandem Combination of Questionnaire‐Based Risk Assessment and Fecal Immunochemical Test Improve the Efficiency of Colorectal Cancer Screening?

International Journal of Cancer, EarlyView.
Colorectal cancer screening reduces disease burden, but the comparative performance of screening strategies remains unclear. This population‐based study shows that the tandem strategy (positive results from both questionnaire‐based risk assessment and fecal immunochemical testing) substantially improved the detection rates of colorectal cancer and ...
Ruyue Liu, Junyi Ji, Xiaolin Wei, Chao Zheng, Nan Zhang, Qiang Sun   +5 more
wiley   +1 more source

Medication Use by Indigenous and Non-Indigenous Australians After a Pharmaceutical Co-Payment Subsidy.

JAMA Health Forum
Saxby K, Liang R, Hall K, Stephens M, Zhang Y, Trivedi AN.   +5 more
europepmc   +1 more source

ESG Performance and Credit Risk: Evidence From Chinese Manufacturing Companies

International Journal of Finance &Economics, EarlyView.
ABSTRACT This study investigates the effect of corporate environmental, social, and governance (ESG) performance on credit risk using a sample of manufacturing firms listed on China's Shanghai and Shenzhen A‐share markets from 2009 to 2021. Employing fixed effects, the generalised method of moments, and instrumental variable models, we find that ...
Yanan Wang, Xiao Zhang, Michal Wojewodzki, Yuxin Jian, Fadey AbiDaoud   +4 more
wiley   +1 more source